Antimicrobial resistance among pathogenic bacteria in Southeast Asia

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 43, Issue 2, 2012, Pages 385-422

  Sri Lestari, Endang ^a   Severin, Juliëtte A ^b   Verbrugh, Henri A ^b  

^a DIPONEGORO UNIVERSITY   (Indonesia)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Antimicrobial resistance; Pathogenic bacteria; Southeast asia

Indexed keywords

EID: 84862559597     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Ang SW, Seah CS, Lee ST. Vancomycin-resistant Enterococcus in the Singapore National Burns Centre: a case report. Ann Acad Med Singapore 1996; 25: 270-2.
2. Angkititrakul S, Chomvarin C, Chaita T, Kanistanon K, Waethewutajarn S. Epidemiology of antimicrobial resistance in Salmonella isolated from pork, chicken meat and humans in Thailand. Southeast Asian J Trop Med Public Health 2005; 36: 1510-5.
3. Anh NT, Cam PD, Dalsgaard A. Antimicrobial resistance of Shigella spp isolated from diarrheal patients between 1989 and 1998 in Vietnam. Southeast Asian J Trop Med Public Health 2001; 32: 856-62.
4. Apisarnthanarak A, Mundy LM. Prevalence, treatment, and outcome of infection due to extended-spectrum beta-lactamase-producing microorganisms. Infect Control Hosp Epidemiol 2006; 27: 326-7.
5. Archer GL. Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 1998; 26: 1179-81.
6. Bax R, Baywater R, Cornaglia G, et al. Surveillance of antimicrobial resistance: what, how and whiter? CMI 2001; 7: 316-25.
7. Bell JM, Turnidge JD, SENTRY APAC Participants. High prevalence of oxacillin-resistant Staphylococcus aureus isolates from hospitalized patients in Asia-Pacific and South Africa: results from SENTRY antimicrobial surveillance program, 1998-1999. J Antimicrob Agent Chemother 2002a; 46: 879-81.
8. Bell JM, Turnidge JD, Jones RN, SENTRY Asia-Pacific Participants. Prevalence of extended-spectrum beta-lactamase-producing Enterobacter cloacae in the Asia-Pacific region: results from the SENTRY Antimicrobial Surveillance Program, 1998 to 2001. Antimicrob Agents Chemother 2003; 47: 3989-93.
9. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN, Sentry APAC Study Group. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002b; 42: 193-8.
10. Biedenbach DJ, Johnson DM, Jones RN. In vitro evaluation of cefepime and other broad-spectrum beta-lactams in eight medical centers in Thailand. The Thailand Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1999; 35: 325-31.
11. Centers for Disease Control and Prevention. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan, 1996. MMWR 1997; 46: 624-6.
12. Cheong YM, Fairuz A, Jegathesan M. Antimicrobial resistance pattern of bacteria isolated from patients seen by private practitioners in the Klang Valley. Singapore Med J 1995; 36: 43-6.
13. Chiew YF. Vancomycin-resistant enterococci. Ann Acad Med Singapore 1997; 26: 808-14.
14. Chiew YF. Detection of extended-spectrum beta-lactamases in a Singapore routine clinical microbiology laboratory. J Hosp Infect 2004; 56: 328-9.
15. Chokephaibulkit K, Srifuengfung S, Mingbanjerdsuk J, et al. Evaluation of susceptibility status of invasive pneumococcal isolates to various antibiotics and risk factors associated with invasive penicillin-nonsusceptible pneumococcal infection: Bangkok 1997-1998. Southeast Asian J Trop Med Public Health 2000; 31: 498-505.
16. Christiansen KJ, Bell JM, Turnidge JD, Jones RN. Antimicrobial activities of garenoxacin (BMS 284756) against Asia-Pacific region clinical isolates from the SENTRY program, 1999 to 2001. Antimicrob Agents Chemother 2004; 48: 2049-55.
17. Cohen ML. Antimicrobial resistance: prognosis for public health. Trends Microbiol 1994; 2: 422-5.
18. Cornaglia G, Hryniewicz W, Jarlier V, et al. European recommendations for antimicrobial resistance surveillance. CMI 2004; 10: 349-83.
19. Critchley IA, Blosser-Middleton R, Jones ME, et al. Antimicrobial resistance among respiratory pathogens collected in Thailand during 1999-2000. J Chemother 2002; 14: 147-54.
20. Danchaivijitr S, Dhiraputra C, Rongrungruang Y, Worajitr M, Jintanothaitavorn D. Antimicrobial susceptibility of community and hospital acquired bacteria. J Med Assoc Thai 2005; 88: S14-25.
21. Djajakusumah T, Sudigdoadi S, Meheus A, Van Dyck E. Plasmid patterns and antimicrobial susceptibilities of Neisseria gonorrhoeae in Bandung, Indonesia. Trans R Soc Trop Med Hyg 1998; 92: 105-7.
22. Doi Y, Husain S, Potoski BA, McCurry KR, Paterson DL. Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 2009; 15: 980-2.
23. Donegan E, Wirawan DN, Muliawan P, et al. Fluoroquinolone-resistant Neisseria gonorrhoeae in Bali, Indonesia: 2004. Sex Transm Dis 2006; 33: 625-9.
24. Erb A, Sturmer T, Marre R, Brenner H. Prevalence of antibiotic resistance in Escherichia coli: overview of geographical, temporal, and methodological variations. Eur J Clin Microbiol Infect Dis 2007; 26: 83-90.
25. Girlich D, Naas T, Leelaporn A, Poirel L, Fennewald M, Nordmann P. Nosocomial spread of the integron-located veb-1-like cassette encoding an extended-spectrum beta-lactamase in Pseudomonas aeruginosa in Thailand. Clin Infect Dis 2002; 34: 603-11.
26. Girlich D, Poirel L, Leelaporn A, et al. Molecular epidemiology of the integron-located VEB-1 extended-spectrum beta-lactamase in nosocomial enterobacterial isolates in Bangkok, Thailand. J Clin Microbiol 2001; 39: 175-82.
27. Goldman DA, Huskins WC. Control of nosocomial antimicrobial resistant bacteria: a strategic priority. Clin Infect Dis 1997; 24: S139-45.
28. Hakanen A, Kotilainen P, Huovinen P, Helenius H, Siitonen A. Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from Southeast Asia. Emerg Infect Dis 2001; 7: 996-1003.
29. Hanson R, Kaneene JB, Padungtod P, Hirokawa K, Zeno C. Prevalence of Salmonella and E. coli, and their resistance to antimicrobial agents, in farming communities in northern Thailand. Southeast Asian J Trop Med Public Health 2002; 33: 120-6.
30. Hanssen AM, Kjeldsen G, Sollid JU. Local variants of Staphylococcal cassette chromosome mec in sporadic methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococci: evidence of horizontal gene transfer? Antimicrob Agents Chemother 2004; 48: 285-96.
31. Hirakata Y, Matsuda J, Miyazaki Y, et al. Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002). Diagn Microbiol Infect Dis 2005; 52: 323-9.
32. Hoban D, Felminghem D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002; 50: 49-59.
33. Hoe CH, Yasin RM, Koh YT, Thong KL. Antimicrobial susceptibility and pulsed-field gel electrophoresis of Shigella sonnei strains in Malaysia (1997-2000). J Appl Microbiol 2005; 99: 133-40.
34. Ieven M, Van Looveren M, Sudigdoadi S, et al. Antimicrobial susceptibilities of Neisseria gonorrhoeae strains isolated in Java, Indonesia. Sex Transm Dis 2003; 30: 25-9.
35. Isenbarger DW, Hoge CW, Srijan A, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis 2002; 8: 175-80.
36. Iversen J, Sandvang D, Srijan A, Cam PD, Dalsgaard A. Characterization of antimicrobial resistance, plasmids, and gene cassettes in Shigella spp from patients in Vietnam. Microb Drug Resist 2003; 9: S17-24.
37. Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992; 29: 19-24.
38. Jitsurong S, Yodsawat J. Prevalence of extended-spectrum beta-lactamases (ESBLs) produced in blood isolates of gram-negative bacteria in a teaching hospital in southern Thailand. Southeast Asian J Trop Med Public Health 2006; 37: 131-5.
39. Johnson DM, Biedenbach DJ, Jones RN. In vitro evaluation of broad-spectrum beta-lactams in the Philippines medical centers: role of fourth-generation cephalosporins. The Philippines Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1999; 35: 291-7.
40. Jones ME, Blosser-Middleton RS, Critchley IA, et al. The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000. Chemotherapy 2002; 48: 232-7.
41. Jones RN, Fritsche TR, Sader HS, Ross JE. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries. Diagn Microbiol Infect Dis 2007a; 59: 199-209.
42. Jones RN, Fritsche TR, Sader HS, Ross JE. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers). Diagn Microbiol Infect Dis 2007b; 59: 309-17.
43. Jones SL, Nguyen VK, Nguyen TM, Athan E. Prevalence of multiresistant Gram-negative organisms in a surgical hospital in Ho Chi Minh City, Vietnam. Trop Med Int Health 2006; 11: 1725 - 30.
44. Klausner JD, Aplasca MR, Mesola VP, Bolan G, Whittington WL, Holmes KK. Correlates of gonococcal infection and of antimicrobial-resistant Neisseria gonorrhoeae among female sex workers, Republic of the Philippines, 1996-1997. J Infect Dis. 1999; 179: 729-33.
45. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994; 7: 117-40.
46. Knapp JS, Mesola VP, Neal SW, et al. Molecular epidemiology, in 1994, of Neisseria gonorrhoeae in Manila and Cebu City, Republic of the Philippines. Sex Transm Dis 1997a; 24: 2-7.
47. Knapp JS, Wongba C, Limpakarnjanarat K, et al. Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995. Sex Transm Dis 1997b; 24: 142-8.
48. Koay AS, Rohani MY, Cheong YM. In-vitro susceptibility of Burkholderia pseudomallei to cefoperazone-sulbactam combination. Med J Malaysia 1997; 52: 158-60.
49. Koh TH, Lin RV. Increasing antimicrobial resistance in clinical isolates of Streptococcus pneumoniae. Ann Acad Med Singapore 1997; 26: 604-8.
50. Kumarasinghe G, Chow C, Chiu C, Cheong YM. In vitro activity of cefoperazone-sulbactam: Singapore experience. Southeast Asian J Trop Med Public Health 1996; 27: 734-7.
51. Kumarasinghe G, Chow C, Koh BL, Chiang KL, Liew HY, Ti TY. Antimicrobial resistance problem in a university hospital. Pathology 1995; 27: 67-70.
52. Kusum M, Wongwanich S, Dhiraputra C, Pongpech P, Naenna P. Occurrence of extended-spectrum beta-lactamase in clinical isolates of Klebsiella pneumoniae in a University Hospital, Thailand. J Med Assoc Thai 2004; 87: 1029-33.
53. Le TA, Sohn AH, Nguyen PT, et al. Microbiology of surgical site infections and associated antimicrobial use among Vietnamese orthopedic and neurosurgical patients. Infect Control Hosp Epidemiol 2006; 27: 855-62.
54. Lee NY, Song JH, Kim S, et al. Carriage of antibiotic-resistant pneumococci among Asian children: a multinational surveillance by Asian Network for Surveillance of Resistant pathogens (ANSORP). Clin Infect Dis 2001; 32: 1463-9.
55. Lee WS, Puthucheary SD, Parasakthi N, Choo KE. Antimicrobial susceptibility and distribution of non-typhoidal Salmonella serovars isolated in Malaysian children. J Trop Pediatr 2003; 49: 37-41.
56. Lesmana M, Lebron CI, Taslim D, et al. In vitro antibiotic susceptibility of Neisseria gonorrhoeae in Jakarta, Indonesia. Antimicrob Agents Chemother 2001; 45: 359-62.
57. Lewis MT, Biedenbach DJ, Jones RN. In vitro evaluation of cefepime and other broad-spectrum beta-lactams against bacteria from Indonesian medical centers. The Indonesia Antimicrobial Resistance Study Group. Diagn Microbiol Infect Dis 1999; 35: 285-90.
58. Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol 2006; 14: 413-20.
59. Malik AS, Ismail A, Pennie RA, Naidu JV. Susceptibility pattern of Streptococcus pneumoniae among pre-school children in Kota Bharu, Malaysia. J Trop Pediatr 1998; 44: 10-14.
60. Mintz E. Shigellosis. In: Heymann DL, ed. Control of communicable diseases manual. 19th ed. Washington DC: American Public Health Association, 2008: 557.
61. Nickerson EK, West TE, Day NP, Peacock SJ. Staphylococcus aureus disease and drug resistance in resource-limited countries in south and east Asia. Lancet Infect Dis 2009; 9: 130-35.
62. Nys S, Okeke IN, Kariuki S, Dinant GJ, Driessen C, Stobberingh EE. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 2004; 54: 952-5.
63. Okeke IN, Klugman KP, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part II: strategies for countainment. Lancet 2005a; 5: 568-80.
64. Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet 2005b; 5: 481-93.
65. Oo KN TM. Serotype distribution and antimicrobial susceptibility of Shigellae isolated from diarrhoeal patients in Yangon, Myanmar. J Diarrhoeal Dis Res 1995; 13: 180-2.
66. Oyofo BA, Subekti D, Tjaniadi P, et al. Enteropathogens associated with acute diarrhea in community and hospital patients in Jakarta, Indonesia. FEMS Immunol Med Microbiol 2002a; 34: 139-46.
67. Oyofo BA, Lesmana M, Subekti D, et al. Surveillance of bacterial pathogens of diarrhea disease in Indonesia. Diagn Microbiol Infect Dis 2002b; 44: 227-34.
68. Parry CM, Diep TS, Wain J, et al. Nasal carriage in Vietnamese children of Streptococcus pneumoniae resistant to multiple antimicrobial agents. Antimicrob Agents Chemother 2000; 44: 484-8.
69. Phetsouvanh R, Phongmany S, Soukaloun D, et al. Causes of community-acquired bacteremia and patterns of antimicrobial resistance in Vientiane, Laos. Am J Trop Med Hyg 2006; 75: 978-85.
70. Raja NS. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases. J Microbiol Immunol Infect 2007; 40: 39-44.
71. Raja NS, Singh NN. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. J Microbiol Immunol Infect 2007; 40: 45-9.
72. Raja NS, Karunakaran R, Ngeow YF, Awang R. Community-acquired vancomycin-resistant Enterococcus faecium: a case report from Malaysia. J Microbiol Methods 2005; 54: 901-3.
73. Rohani MY, Raudzah A, Lau MG, et al. Susceptibility pattern of Staphylococcus aureus isolated in Malaysian hospitals. Int J Antimicrob Agents 2000; 13: 209-13.
74. Schultsz C, Vien le M, Campbell JI, et al. Changes in the nasal carriage of drug-resistant Streptococcus pneumoniae in urban and rural Vietnamese schoolchildren. Trans R Soc Trop Med Hyg 2007; 101: 484-92.
75. Soh SW, Poh CL, Lin RV. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates from pediatric patients in Singapore. Antimicrob Agents Chemother 2000; 44: 2193-96.
76. Song JH, Chang HH, Suh JY, et al. Macrolide resistance and genotypic characterization of Streptococcus pneumoniae in Asian Network for Surveillance of Resistant Pathogens (ANSORP). J Antimicrob Chemother 2004b; 53: 457-63.
77. Song JH, Hiramatsu K, Suh JY, et al. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 2004a; 48: 4926-8.
78. Song JH, Jung SI, Ko KS, et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP Study). Antimicrob Agents Chemother 2004c; 48: 2101-7.
79. Song JH, Lee NY, Ichiyama S, et al. Spread of drug resistant Streptococcus pneumoniae in Asian countries: Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study. Clin Infect Dis 1999; 28: 1206-11.
80. Srifuengfung S, Chokephaibulkit K, Yungyuen T, Tribuddharat C. Bacteremia and antimicrobial susceptibilities in HIV-infected patients at Siriraj Hospital. Southeast Asian J Trop Med Public Health 2005a; 36: 347-51.
81. Srifuengfung S, Chokephaibulkit K, Yungyuen T, Tribuddharat C. Salmonella meningitis and antimicrobial susceptibilities. Southeast Asian J Trop Med Public Health 2005b; 36: 312-16.
82. Su X, Hutapea N, Tapsall JW, Lind I. Plasmid-mediated resistance of Neisseria gonorrhoeae strains isolated from female sex workers in North Sumatra, Indonesia, 1996. Sex Transm Dis 2003; 30: 178-82.
83. Subekti DS, Lesmana M, Tjaniadi P, et al. Prevalence of enterotoxigenic Escherichia coli (ETEC) in hospitalized acute diarrhea patients in Denpasar, Bali, Indonesia. Diagn Microbiol Infect Dis 2003; 47: 399-405.
84. Sutrisna A, Soebjakto O, Wignall A, et al. Increasing resistance to ciprofloxacin and other antibiotics in Neisseria gonorrhoeae from East Java and Papua, Indonesia, in 2004. implications for treatment. Int J STD AIDS 2006; 17: 810-12.
85. Tan HH, Tay YK, Goh CL. Bacterial skin infections at a tertiary dermatological centre. Singapore Med J 1998; 39: 353-6.
86. Tapsall JW. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 1998. Commun Dis Intell 2000; 24: 1-4.
87. Tapsall JW. Antibiotic resistance in Neisseria gonorrhoeae. Clin Infect Dis 2005; 41: S263-68.
88. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: some possible remedies. Expert Rev Anti Infect Ther 2006; 4: 619-28.
89. Tee NW, Lin RV. Serotypes and antimicrobial resistance in Haemophilus influenzae in a hospital practice. Ann Acad Med Singapore 1996; 25: 184-7.
90. Tenover FC, Hughes JM. The challenges of emerging infectious diseases: development and spread of multiply-resistant bacterial pathogens. Emerg Infect Dis 1996; 275: 300-4.
91. Thongpiyapoom S, Narong MN, Suwalak N, et al. Device-associated infections and patterns of antimicrobial resistance in a medical-surgical intensive care unit in a university hospital in Thailand. J Med Assoc Thai 2004; 87: 819-24.
92. Tjaniadi P, Lesmana M, Subekti D, et al. Antimicrobial resistance of bacterial pathogens associated with diarrheal patients in Indonesia. Am J Trop Med Hyg 2003; 68: 666-70.
93. Tristram S, Jacob MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 2007; 20: 368-89.
94. Wang TKF, Ho PL. The challenge of antibiotic resistance in Asia: problem and solutions. Med Progress 2003; 8: 41-9.
95. World Health Organization (WHO). Antimicrobial resistance in gonococci, WHO Western Pacific Region, 1996. Commun Dis Intell 1997a; 21: 349-53.
96. World Health Organization (WHO). The Gonococcal Antimicrobial Surveillance Programme (GSAP). Wkly Epidemiol Rec 1997b; 72: 25-7.
97. World Health Organization (WHO). Resistance in gonococci isolated in the WHO Western Pasific Region to various antimicrobials used in the treatment of gonorrhoeae, 1997. Commun Dis Intell 1998; 22: 288-91.
98. World Health Organization (WHO). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000. Commun Dis Intell 2001; 25: 274-6.
99. World Health Organization (WHO). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2001. Commun Dis Intell 2002; 26: 541-5.
100. World Health Organization (WHO). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2002. Commun Dis Intell 2003; 27: 488-91.
101. World Health Organization (WHO). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2003. Commun Dis Intell 2005; 29: 62-4.
102. World Health Organization (WHO). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004. Commun Dis Intell 2006a; 30: 129-32.
103. World Health Organization (WHO). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2005. Commun Dis Intell 2006b; 30: 430-3.
104. Wong JS, Mohd Azri ZA, Subramaniam G, Ho SE, Palasubramaniam S, Navaratnam P. beta-Lactam resistance phenotype determination in Escherichia coli isolates from University Malaya Medical Centre. Malays J Pathol 2003; 25: 113-9.
105. Workowski KA, Berman SM, Douglas JMJ. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med 2008; 148: 606-13.
106. Wuthiekanun V, Cheng AC, Chierakul W, et al. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J Antimicrob Chemother 2005; 55: 1029-31.